Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$168M |
| 2 |
CenterPoint Energy
CNP
|
+$151M |
| 3 |
Netflix
NFLX
|
+$132M |
| 4 |
Equifax
EFX
|
+$132M |
| 5 |
Sempra
SRE
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$335M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$166M |
| 3 |
CMA
Comerica
CMA
|
+$164M |
| 4 |
DuPont de Nemours
DD
|
+$144M |
| 5 |
Dollar Tree
DLTR
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.25% |
| 2 | Technology | 11.65% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Industrials | 8.5% |
| 5 | Healthcare | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Realty Income
O
$59.2B
| $39.1M | 0.18% |
708,943
+5,500
| +0.8% | +$303K |
|
152
Aptiv
APTV
$10B
| $39.1M | 0.18% |
+465,698
| New | +$42.6M |
|
153
Novartis
NVS
$302B
| $39M | 0.18% |
505,304
+112,376
| +29% | +$8.31M |
|
|
HOLX
154
DELISTED
Hologic
HOLX
| $39M | 0.18% |
951,272
+776,059
| +443% | +$31.4M |
|
155
Ollie's Bargain Outlet
OLLI
$4.6B
| $38.9M | 0.18% |
404,793
+321,109
| +384% | +$25.6M |
|
156
Bloomin' Brands
BLMN
$996M
| $38.5M | 0.17% |
1,945,546
-810,210
| -29% | -$15.8M |
|
157
Dentsply Sirona
XRAY
$2.18B
| $38.4M | 0.17% |
1,017,192
+991,019
| +3,786% | +$41.3M |
|
|
IRBT
158
DELISTED
iRobot
IRBT
| $38.1M | 0.17% |
346,309
+94,550
| +38% | +$8.9M |
|
159
Union Pacific
UNP
$183B
| $38M | 0.17% |
233,167
+226,807
| +3,566% | +$34.1M |
|
160
Lear
LEA
$8.56B
| $37.9M | 0.17% |
261,603
+197,360
| +307% | +$33.8M |
|
161
W.R. Berkley
WRB
$25.5B
| $37.6M | 0.17% |
1,588,454
+8,279
| +0.5% | +$188K |
|
162
CALL
Bristol-Myers Squibb
BMY
$137B
| $37.4M | 0.17% |
615,000
-538,000
| -47% | -$31.9M |
|
|
ANSS
163
DELISTED
Ansys
ANSS
| $36.7M | 0.17% |
196,621
+25,892
| +15% | +$4.63M |
|
|
PVTL
164
DELISTED
Pivotal Software, Inc.
PVTL
| $36.6M | 0.17% |
1,871,197
+1,525,806
| +442% | +$37.2M |
|
165
Conduent
CNDT
$250M
| $36.6M | 0.17% |
+1,624,855
| New | +$33.3M |
|
166
Hubbell
HUBB
$24.8B
| $36.2M | 0.16% |
271,226
-205,071
| -43% | -$25.2M |
|
|
ELLI
167
DELISTED
Ellie Mae Inc
ELLI
| $36.2M | 0.16% |
381,905
+219,778
| +136% | +$22.6M |
|
168
Applied Materials
AMAT
$391B
| $36.1M | 0.16% |
934,791
+323,214
| +53% | +$14.3M |
|
169
nVent Electric
NVT
$24.6B
| $36.1M | 0.16% |
1,329,923
+814,914
| +158% | +$22.2M |
|
170
Take-Two Interactive
TTWO
$44.8B
| $36M | 0.16% |
260,980
-336,441
| -56% | -$42.9M |
|
171
CubeSmart
CUBE
$9.21B
| $35.9M | 0.16% |
1,258,430
+577,836
| +85% | +$17.7M |
|
|
CTRA
172
DELISTED
Coterra Energy
CTRA
| $35.8M | 0.16% |
1,591,819
+1,460,068
| +1,108% | +$34.1M |
|
173
US Foods
USFD
$23.7B
| $35.7M | 0.16% |
1,158,349
-1,656,769
| -59% | -$57.3M |
|
|
MNDT
174
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $35.1M | 0.16% |
+2,064,552
| New | +$33M |
|
175
Teva Pharmaceuticals
TEVA
$43.5B
| $35M | 0.16% |
1,626,628
+670,720
| +70% | +$15.6M |
|
Similar funds
Dmitry Balyasny's Q3 2018 Portfolio in Review
As of Q3 2018, Dmitry Balyasny held 2,302 positions worth $22B, up 0% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny withdrew a net $916M in Q3 2018, closing 688 positions and reducing 537 holdings. Its most notable exit was DuPont de Nemours, an estimated $144M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in Equifax worth $132M.
- Dmitry Balyasny's largest Q3 2018 buy was Equifax: 1,013,016 shares worth $132M.
- Dmitry Balyasny added most to Walt Disney in Q3 2018, an estimated $168M increase.
- Dmitry Balyasny's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $335M.
- Dmitry Balyasny fully exited DuPont de Nemours in Q3 2018, selling an estimated $144M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $22B portfolio in Q3 2018.
- Dmitry Balyasny opened 567 new positions and closed 688 in Q3 2018.
- Dmitry Balyasny's portfolio value rose 0% quarter-over-quarter to $22B.
Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.